ARCHIVES

New Phase III Follow-Up Data of Yervoy Trial Shows 19 Percent Survival at Four Years

This article is from The Cancer Letter archive.

Vol. 35 No. 10 | October 26, 2012

Download PDF Visit The Full Archive

Related Articles

NCI-Approved Clinical Trials

November 24, 2006

M.D. Anderson Must Evaluate 8 Patients In Controversial Study

May 31, 1996

In Brief: Clinical Education Program to Be Phased Out; Ken Endicott Retires From Grupenhoff Firm

January 31, 1986

In Brief: Von Hoff to Direct Arizona Cancer Center; American Health Foundation Appoints Nixon

April 23, 1999

ACS To Implement Cancer Response Systems Nationwide

August 2, 1985

DCBDC Board Ok’s New Initiative For Training

November 16, 1990